Early iron reduction programme for thalassaemia patients after bone marrow transplantation.

C K Li, D H Lai, M M Shing, K W Chik, V Lee, P M Yuen

Journal: Bone marrow transplantation 2000;25(6):653-6

PMID: 10734300

Full Text on Nature Publishing Group View on PubMed

Abstract

Thirty thalassaemia patients received iron reduction starting at around 3 months post transplant. Sixteen received desferrioxamine and nine had phlebotomy, five patients had desferrioxamine followed by phlebotomy. The desferrioxamine group had higher serum ferritin levels at the start of iron reduction as compared to the phlebotomy group (5292 vs 2453 microg/l, P EQ 0.001). After 444 and 407 days of iron reduction, serum ferritins at cessation of iron reduction in both groups was similar (665 vs 588 microg/l). The rate of decline of serum ferritin in both groups was similar. There was no graft rejection during the programme. Early institution of iron reduction in ex-thalassaemia is safe.

Address: Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong.

DOI: 10.1038/sj.bmt.1702212

Link outs

Free resources

Medical:

https://medlineplus.gov/bonemarrowtransplantation....

Subscription / membership required

Full Text Sources:

https://doi.org/10.1038/sj.bmt.1702212

MeSH Terms: Adolescent, Adult, Alanine Transaminase, Bone Marrow Transplantation, Chelating Agents, Child, Child, Preschool, Deferoxamine, Ferritins, Hemoglobins, Humans, Iron, Iron Overload, Liver, Phlebotomy, Time Factors, Transplantation Chimera, Transplantation, Homologous, beta-Thalassemia